Gliclazide protects 3T3L1 adipocytes against insulin resistance induced by hydrogen peroxide with restoration of GLUT4 translocation

Metabolism: Clinical and Experimental

Volumn 55, Issue 6, 2006, Pages 722-730

  Shimoyama, Tatsuhiro ^a   Yamaguchi, Shinya ^a   Takahashi, Kazuto ^a   Katsuta, Hidenori ^a   Ito, Eisuke ^a   Seki, Hiroyuki ^a   Ushikawa, Kenji ^a   Katahira, Hiroshi ^a   Yoshimoto, Katsuhiko ^a   Ohno, Hideki ^a   Nagamatsu, Shinya ^a   Ishida, Hitoshi ^a  

^a KYORIN UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; GLIBENCLAMIDE; GLICLAZIDE; GLUCOSE TRANSPORTER 4; HYDROGEN PEROXIDE; INSULIN; SULFONYLUREA DERIVATIVE;

ADIPOCYTE; ARTICLE; CELL STRAIN 3T3; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; GLUCOSE TRANSPORT; HUMAN; HUMAN CELL; INCUBATION TIME; INSULIN RESISTANCE; INSULIN SENSITIVITY; OXIDATIVE STRESS; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE;

3T3-L1 CELLS; ADIPOCYTES; GLICLAZIDE; GLUCOSE; GLUCOSE TRANSPORTER TYPE 4; HYDROGEN PEROXIDE; HYPOGLYCEMIC AGENTS; INSULIN; INSULIN RESISTANCE; MICE; OXIDATIVE STRESS; PROTEIN TRANSPORT;

EID: 33646514404     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.metabol.2006.01.019     Document Type: Article

References (39)

1. Nourooz-Zadeh J., Tajaddini-Sarmadi J., McCarthy S., Betteridge D.J., and Wolff S.P. Elevated levels of authentic plasma hydroperoxides in NIDDM. Diabetes 44 (1995) 1054-1058
2. Cross C.E., Halliwell B., Borish E.T., et al. Oxygen radicals and human disease. Ann Intern Med 107 (1987) 526-545
3. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329 (1993) 977-986
4. Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature 414 (2001) 813-820
5. Yki-Järvinen H. Glucose toxicity. Endocr Rev 13 (1992) 415-431
6. Evans J.L., Goldfine I.D., Maddux B.A., and Grodsky G.M. Are oxidative stress-activated signaling pathways mediators of insulin resistance and β-cell dysfunction?. Diabetes 52 (2003) 1-8
7. Tanaka Y., Gleason C.E., Tran P.O.T., Harmon J.S., and Robertson R.P. Prevention of glucose toxicity in HIT-T15 cells and Zucker diabetic fatty rats by antioxidants. Proc Natl Acad Sci U S A 96 (1999) 10857-10862
8. Kaneto H., Kajimoto Y., Miyagawa J., et al. Beneficial effects of antioxidant in diabetes: possible protection of pancreatic β-cells against glucose toxicity. Diabetes 48 (1999) 2398-2406
9. Furukawa S., Fujita T., Shimabukuro M., et al. Increased oxidative stress in obesity and its impact on metabolic syndrome. J Clin Invest 114 (2004) 1752-1761
10. Tirosh A., Potashnik R., Bashan N., and Rudich A. Oxidative stress disrupts insulin-induced cellular redistribution of insulin receptor substrate-1 and phosphatidylinositol 3-kinase in 3T3-L1 adipocytes. J Biol Chem 274 (1999) 10595-10602
11. + channels and insulin secretion: their role in health and disease. Diabetologia 42 (1999) 903-919
12. Desfaits A.-C., Serri O., and Renier G. Gliclazide decrease cell-mediated low-density lipoprotein (LDL) oxidation and reduces monocyte adhesion to endothelial cells induced by oxidatively modified LDL. Metabolism 46 (1997) 1150-1156
13. Kimoto K., Suzuki K., Kizaki T., et al. Gliclazide protects pancreatic β-cells from damage by hydrogen peroxide. Biochem Biophys Res Commun 303 (2003) 112-119
14. Scott N.A., Jennings P.E., Brown J., and Belch J.J.F. Gliclazide: a general free radical scavenger. Eur J Pharmacol 208 (1991) 175-177
15. Noda Y., Mori A., and Packer L. Gliclazide scavenges hydroxyl, superoxide and nitric oxide radicals: an ESR study. Res Commun Mol Pathol Pharmacol 96 (1997) 115-124
16. O'Brien R.C., Luo M., Balazs N., and Mercuri J. In vitro and in vivo antioxidant properties of gliclazide. J Diabetes Complications 14 (2000) 201-206
17. Nakamichi Y., Ohara-Imaizumi M., Ishida H., and Nagamatsu S. An insulin-related peptide expressed in 3T3L1 adipocytes is localized in GLUT4 vesicles and secreted in response to exogenous insulin, which augments the insulin-stimulated glucose uptake. J Cell Sci 116 (2003) 73-79
18. 2. J Biol Chem 274 (1999) 25078-25084
19. Tanaka Y., Tran P.O.T., Harmon J., and Robertson R.P. A role of glutathione peroxidase in protecting pancreatic β cells against oxidative stress in a model of glucose toxicity. Proc Natl Acad Sci U S A 99 (2002) 12363-12368
20. Schrauwen P., and Hesselink M.K.C. Oxidative capacity, lipotoxicity, and mitochondrial damage in type 2 diabetes. Diabetes 53 (2004) 1412-1417
21. Nishikawa T., Edelstein D., and Brownlee M. The missing link: a signal unifying mechanism for diabetic complications. Kidney Int 58 (2000) S26-S30
22. Paolisso G., and Giugliano D. Oxidative stress and insulin action: is there a relationship?. Diabetologia 39 (1996) 357-363
23. Maddux B.A., See W., Lawrence J.C., Goldfine A.L., Goldfine I.D., and Evans J.L. Protection against oxidative stress-induced insulin resistance in rat L6 muscle cells by micromolar concentrations of α-lipoic acid. Diabetes 50 (2001) 404-410
24. Rudich A., Tirosh A., Potashnik R., Khamaisi M., and Bashan N. Lipoic acid protects against oxidative stress-induced impairment of insulin stimulation of protein kinase B and glucose transport in 3T3-L1 adipocytes. Diabetologia 42 (1999) 949-957
25. Jacob S., Lehmann R., Rett K., and Häring H.-U. Oxidative stress and insulin action: a role for antioxidants?. In: Pecker L., Rösen P., Tritschler H.J., King G.L., and Azzi A. (Eds). Antioxidant in diabetes management (2000), Marcel Dekker, New York 319-338
26. Evans J.L., and Goldfine I.D. α-Lipoic acid: a multi-functional antioxidant that improves insulin sensitivity in patients with type 2 diabetes. Diabetes Technol Ther 2 (2000) 401-413
27. 2 on adipocyte glucose transport. J Cell Physiol 110 (1982) 323-328
28. 2+-dependent thiol activation of fat cell glucose utilization. J Biol Chem 249 (1974) 1001-1006
29. May J.M., and de Haen C. The insulin-like effect of hydrogen peroxide on pathways of lipid synthesis in rat adipocytes. J Biol Chem 254 (1979) 9017-9021
30. Kyriakis J.M., and Avruch J. Sounding the alarm: protein kinase cascades activated by stress and inflammation. J Biol Chem 271 (1996) 24313-24316
31. Paz K., Hemi R., LeRoith D., et al. A molecular basis for insulin resistance: elevated serine/threonine phosphorylation of IRS-1 and IRS-2 inhibits their binding to the juxtamembrane region of the insulin receptor and impairs their ability to undergo insulin-induced tyrosine phosphorylation. J Biol Chem 272 (1997) 29911-29918
32. Birnbaum M.J. Turning down insulin signaling. J Clin Invest 108 (2001) 655-659
33. 307. J Biol Chem 275 (2000) 9047-9054
34. Blair A.S., Hajduch E., Litherland G.J., and Hundal H.S. Regulation of glucose transport and glycogen synthesis in L6 muscle cells during oxidative stress. J Biol Chem 274 (1999) 36293-36299
35. Yuan M., Konstantopoulos N., Lee J., et al. Reversal of obesity- and diet-induced insulin resistance with salicylates or targeted disruption of IKKβ. Science 293 (2001) 1673-1677
36. Kim J.K., Kim Y.-J., Fillmore J.J., et al. Prevention of fat-induced insulin resistance by salicylate. J Clin Invest 108 (2001) 437-446
37. Potashnik R., Bloch-Damti A., Bashan N., and Rudich A. IRS1 degradation and increased serine phosphorylation cannot predict the degree of metabolic insulin resistance induced by oxidative stress. Diabetologia 46 (2003) 639-648
38. Shiba T., Kajinuma H., Suzuki K., et al. Serum gliclazide concentration in diabetic patients: relationship between gliclazide dose and serum concentration. Diabetes Res Clin Pract 2 (1986) 301-306
39. Rodríguez E., Pulido N., Romero R., Arrieta F., Panadero A., and Rovira A. Phosphatidylinositol 3-kinase activation is required for sulfonylurea stimulation of glucose transport in rat skeletal muscle. Endocrinology 145 (2004) 679-685